Table 2.
Characteristic | Value |
---|---|
Technical success | 27 (100) |
Clinical success | 27 (100) |
Adverse events | 0 |
Follow-up between 5F plastic stenting and cholecystectomy | |
Duration until cholecystectomy, days | 7 (5–8) |
Dislodgement of stent before cholecystectomy | 0 |
New onset and aggravation of biliary problems | 0 |
Normalization of bilirubin after 5F plastic stenting | 26 (96.3) |
Qualitative data and quantitative data are presented as number (%) and median (interquartile range), respectively.